Author

Øivind Kvammen

Observed names: Kvammen, Øivind, Oivind Kvammen, Ø Kvammen, Ø. Kvammen

Institution: Helse Møre og Romsdal HF

Observed institutions: Norwegian University of Science and Technology, Central Norway Regional Health Authority, Ålesund Hospital, St Olav's University Hospital, Helse Møre og Romsdal HF

ORCID: 0000-0003-0192-3264

Observed ORCID: 0000-0003-0192-3264

OpenAlex ID: A5048220987

Testicular Cancer in the Cisplatin Era: Causes of Death and Mortality Rates in a Population-Based Cohort

2021 · Ragnhild Hellesnes, Tor Åge Myklebust, et al. · Journal of Clinical Oncology · 106

B-Lymphocyte Depletion in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial

2019 · Øystein Fluge, Ingrid G. Rekeland, et al. · Annals of Internal Medicine · 94

Long-term Relative Survival after Diagnosis of Testicular Germ Cell Tumor

2016 · Øivind Kvammen, Tor Å. Myklebust, et al. · Cancer Epidemiology Biomarkers & Prevention · 69

Continuing increased risk of second cancer in long‐term testicular cancer survivors after treatment in the cisplatin era

2019 · Ragnhild Hellesnes, Øivind Kvammen, et al. · International Journal of Cancer · 64

Causes of inferior relative survival after testicular germ cell tumor diagnosed 1953–2015: A population-based prospective cohort study

2019 · Øivind Kvammen, Tor Åge Myklebust, et al. · PLoS ONE · 23

Metachronous Contralateral Testicular Cancer in the Cisplatin Era: A Population-Based Cohort Study

2020 · Ragnhild Hellesnes, Tor Åge Myklebust, et al. · Journal of Clinical Oncology · 17

Late relapses in testicular cancer: Results from a national cohort.

2022 · Torgrim Tandstad, Ragnhild Hellesnes, et al. · Journal of Clinical Oncology · 7

Testicular cancer in the cisplatin era: Causes of death and mortality rates in a population-based cohort.

2021 · Ragnhild Hellesnes, Tor Åge Myklebust, et al. · Journal of Clinical Oncology · 5

Testicular cancer risk according to county of birth and county of diagnosis in Norway, 1958–2007

2012 · Øivind Kvammen, Steinar Tretli, et al. · Acta Oncologica · 2

735P Causes of death in a complete cohort of testicular cancer patients diagnosed in Norway 1980-2009, with detailed treatment information

2023 · Ø. Kvammen, R. Hellesnes, et al. · Annals of Oncology · 1

708MO Metachronous contralateral testicular cancer in the cisplatin era: A population-based cohort study

2020 · R. Hellesnes, T.Å. Myklebust, et al. · Annals of Oncology · 1

Long-term causes of relative excess mortality after diagnosis of testicular germ cell tumor.

2017 · Oivind Kvammen, Myklebust Åge Tor, et al. · Journal of Clinical Oncology · 1

Increased risk of non-germ cell second cancer (SC) after cisplatin-based chemotherapy (CBCT) in 1-year testicular cancer (TC) survivors (TCS)

2018 · R. Hellesnes, Ø Kvammen, et al. · Annals of Oncology

Works count: 14

Citation count: 390

H-index: 7

I10-index: 6